Next Generation Liver Biomarkers
Posted: August 28, 2019
Panels of biomarkers for NAFLD/NASH, AH, and DILI research, featuring K18
Diapharma offers non-invasive biomarker assays for research of liver injury, metabolic syndrome, and associated pathologies.
Explore M30® and M65® Cytokeratin/Keratin 18 ELISAs for studying hepatocyte apoptosis/necrosis, and see what’s new in biomarkers for NASH, AH, and DILI research, including L-FABP and Mac‐2 BP, and Noggin.
VISIT US AT BOOTH #1224
FOR RESEARCH USE ONLY IN THE U.S. AND CANADA
Diapharma invites you to stop by booth #1224 while attending The Liver Meeting® 2019 in Boston, MA, November 8 – 12.
8948 Beckett Road
West Chester, OH, 45069